Page last updated: 2024-12-05

4-n-bis(2-chloroethyl)aminobenzoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-N-bis(2-chloroethyl)aminobenzoic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14356
CHEMBL ID12293
SCHEMBL ID766052
MeSH IDM0163591

Synonyms (24)

Synonym
benzoic acid, p-[bis(2-chloroethyl)amino]-
nsc-26276
4-[bis(2-chloroethyl)amino]benzoic acid
wln: qvr dn2g2g
benzoic acid, 4-[bis(2-chloroethyl)amino]-
nsc26276
1141-37-3
benzoic acid nitrogen mustard
benzoic acid, p-(bis(2-chloroethyl)amino)-
brn 0988858
4-n-bis(2-chloroethyl)aminobenzoic acid
nsc 26276
4-(bis(2-chloroethyl)amino)benzoic acid
benzoic acid, 4-(bis(2-chloroethyl)amino)-
p-n,n-bis(2-chloroethyl)aminobenzoic acid
CHEMBL12293
kd3azx3r33 ,
unii-kd3azx3r33
4-[bis-(2-chloroethyl)amino] benzoic acid
SCHEMBL766052
DTXSID40150654
4-[bis(2-chloroethyl)amino] benzoic acid
p-(bis(2-chloroethyl)amino)benzoic acid
4-[bis-(2-chloroethyl)amino]benzoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (37)

Assay IDTitleYearJournalArticle
AID1132020Antitumor activity against rat Walker 256 cells allografted in rat1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships in antitumor aniline mustards.
AID1421496Cytotoxicity against human LO2 cells assessed as decrease in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Oct-05, Volume: 158Synthesis of scutellarein derivatives with antiproliferative activity and selectivity through the intrinsic pathway.
AID1383599Selectivity index, ratio of IC50 for human LO2 cells to IC50 for human Bel7402 cells2018European journal of medicinal chemistry, Apr-25, Volume: 150Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation.
AID1421495Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Oct-05, Volume: 158Synthesis of scutellarein derivatives with antiproliferative activity and selectivity through the intrinsic pathway.
AID24282Chemical half-life in percholate at 37 degree was determined1994Journal of medicinal chemistry, Jul-22, Volume: 37, Issue:15
Novel prodrugs of alkylating agents derived from 2-fluoro- and 3-fluorobenzoic acids for antibody-directed enzyme prodrug therapy.
AID1393842Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Feb-25, Volume: 146Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
AID1777556Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK-8 assay2021Bioorganic & medicinal chemistry, 09-01, Volume: 45Design and synthesis of β-carboline derivatives with nitrogen mustard moieties against breast cancer.
AID1421494Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Oct-05, Volume: 158Synthesis of scutellarein derivatives with antiproliferative activity and selectivity through the intrinsic pathway.
AID1465329Antiproliferative activity against human PC3 cells treated for 24 hrs measured after 72 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity.
AID1777558Cytotoxicity against human MCF-10A cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK-8 assay2021Bioorganic & medicinal chemistry, 09-01, Volume: 45Design and synthesis of β-carboline derivatives with nitrogen mustard moieties against breast cancer.
AID1777557Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell proliferation measured after 72 hrs by CCK-8 assay2021Bioorganic & medicinal chemistry, 09-01, Volume: 45Design and synthesis of β-carboline derivatives with nitrogen mustard moieties against breast cancer.
AID1393843Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Feb-25, Volume: 146Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
AID102183Inhibitory concentration was evaluated against colorectal tumar cell line LoVo1996Journal of medicinal chemistry, Mar-01, Volume: 39, Issue:5
New mustard prodrugs for antibody-directed enzyme prodrug therapy: alternatives to the amide link.
AID1185080Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 72 hrs by MTT assay2014ACS medicinal chemistry letters, Jul-10, Volume: 5, Issue:7
Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates.
AID1465331Antiproliferative activity against human THP1 cells treated for 24 hrs measured after 72 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity.
AID1185082Antiproliferative activity against human MGC803 cells assessed as growth inhibition after 72 hrs by MTT assay2014ACS medicinal chemistry letters, Jul-10, Volume: 5, Issue:7
Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates.
AID91909The compound was tested for cytotoxicity against human JAR, choriocarcinoma cell line.1990Journal of medicinal chemistry, Feb, Volume: 33, Issue:2
Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2.
AID1383594Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation.
AID1185079Antiproliferative activity against human K562 cells assessed as growth inhibition after 72 hrs by MTT assay2014ACS medicinal chemistry letters, Jul-10, Volume: 5, Issue:7
Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates.
AID1393846Antiproliferative activity against human LO2 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Feb-25, Volume: 146Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
AID1185088Cytotoxicity against human L02 cells by MTT assay2014ACS medicinal chemistry letters, Jul-10, Volume: 5, Issue:7
Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates.
AID1393847Selectivity index, ratio of IC50 for human LO2 cells to IC50 for human Bel7402 cells2018European journal of medicinal chemistry, Feb-25, Volume: 146Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
AID101135The compound was tested for cytotoxicity against human LS174T,colorectal cell line.1990Journal of medicinal chemistry, Feb, Volume: 33, Issue:2
Novel prodrugs which are activated to cytotoxic alkylating agents by carboxypeptidase G2.
AID1383598Antiproliferative activity against human LO2 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation.
AID1465330Antiproliferative activity against human HepG2 cells treated for 24 hrs measured after 72 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity.
AID1465332Antiproliferative activity against human HL60 cells treated for 24 hrs measured after 72 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity.
AID1383595Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation.
AID1185087Anticancer activity against human Bel7402 cells assessed as growth inhibition by MTT assay2014ACS medicinal chemistry letters, Jul-10, Volume: 5, Issue:7
Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates.
AID1060756Antitumor activity against mouse B16F10 cells xenografted in C57BL/6 mouse assessed as reduction of tumor size at 100 ug administered as intratumorally for 3 days2014European journal of medicinal chemistry, Jan, Volume: 71Synthesis and analysis of activity of a potential anti-melanoma prodrug with a hydrazine linker.
AID1393845Antiproliferative activity against human Bel7402/5-FU cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Feb-25, Volume: 146Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
AID1383597Antiproliferative activity against human Bel7402/5-FU cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation.
AID1421493Antiproliferative activity against human A549 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Oct-05, Volume: 158Synthesis of scutellarein derivatives with antiproliferative activity and selectivity through the intrinsic pathway.
AID1383596Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Apr-25, Volume: 150Novel hybrids of brefeldin A and nitrogen mustards with improved antiproliferative selectivity: Design, synthesis and antitumor biological evaluation.
AID1465333Antiproliferative activity against human PBMC treated for 24 hrs measured after 72 hrs by MTT assay2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Design and synthesis of novel nitrogen mustard-evodiamine hybrids with selective antiproliferative activity.
AID1132021Toxicity in rat allografted with rat Walker 256 cells1978Journal of medicinal chemistry, Jan, Volume: 21, Issue:1
Structure-activity relationships in antitumor aniline mustards.
AID1185081Antiproliferative activity against human Bel7402 cells assessed as growth inhibition after 72 hrs by MTT assay2014ACS medicinal chemistry letters, Jul-10, Volume: 5, Issue:7
Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates.
AID1393844Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay2018European journal of medicinal chemistry, Feb-25, Volume: 146Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (15.38)18.7374
1990's4 (30.77)18.2507
2000's0 (0.00)29.6817
2010's6 (46.15)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.92 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.56 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]